Fabrication and Characterization of Oxygen-Generating Polylactic Acid/Calcium Peroxide Composite Filaments for Bone Scaffolds.
3D printing filament
bone scaffold
calcium peroxide
oxygen releases
poly lactic acid
tissue engineering
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
20 Apr 2023
20 Apr 2023
Historique:
received:
27
03
2023
revised:
13
04
2023
accepted:
14
04
2023
medline:
28
4
2023
pubmed:
28
4
2023
entrez:
28
4
2023
Statut:
epublish
Résumé
The latest advancements in bone scaffold technology have introduced novel biomaterials that have the ability to generate oxygen when implanted, improving cell viability and tissue maturation. In this paper, we present a new oxygen-generating polylactic acid (PLA)/calcium peroxide (CPO) composite filament that can be used in 3D printing scaffolds. The composite material was prepared using a wet solution mixing method, followed by drying and hot melting extrusion. The concentration of calcium peroxide in the composite varied from 0% to 9%. The prepared filaments were characterized in terms of the presence of calcium peroxide, the generated oxygen release, porosity, and antibacterial activities. Data obtained from scanning electron microscopy and X-ray diffraction showed that the calcium peroxide remained stable in the composite. The maximum calcium and oxygen release was observed in filaments with a 6% calcium peroxide content. In addition, bacterial inhibition was achieved in samples with a calcium peroxide content of 6% or higher. These results indicate that an optimized PLA filament with a 6% calcium peroxide content holds great promise for improving bone generation through bone cell oxygenation and resistance to bacterial infections.
Identifiants
pubmed: 37111384
pii: ph16040627
doi: 10.3390/ph16040627
pmc: PMC10143609
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Adv Drug Deliv Rev. 2016 Dec 15;107:163-175
pubmed: 27426411
Int Endod J. 1999 Sep;32(5):361-9
pubmed: 10551109
Polymers (Basel). 2020 May 29;12(6):
pubmed: 32485817
Biomaterials. 2016 May;89:157-65
pubmed: 26970510
PLoS One. 2013 Aug 26;8(8):e72485
pubmed: 23991116
Int J Pharm. 2014 Nov 20;475(1-2):130-7
pubmed: 25173637
J Biomed Mater Res B Appl Biomater. 2020 Apr;108(3):1097-1106
pubmed: 31393674
Tissue Eng Part B Rev. 2017 Feb;23(1):9-26
pubmed: 27405960
Polymers (Basel). 2020 Apr 02;12(4):
pubmed: 32252290
ACS Biomater Sci Eng. 2017 Sep 11;3(9):1964-1971
pubmed: 33440552
Biomaterials. 2015;53:583-91
pubmed: 25890754
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12380-12385
pubmed: 27791101
Mater Sci Eng C Mater Biol Appl. 2018 Mar 1;84:236-242
pubmed: 29519434
Biomed Mater. 2016 Feb 02;11(1):015011
pubmed: 26836023
Prog Mater Sci. 2018 Apr;93:45-111
pubmed: 31406390
Trends Biotechnol. 2016 Dec;34(12):1010-1021
pubmed: 27325423
Biomaterials. 2015 Jun;52:376-84
pubmed: 25818444
J Biol Eng. 2015 Mar 01;9:4
pubmed: 25866560
J Mater Sci Mater Med. 2015 Jul;26(7):207
pubmed: 26155978
J Biomater Sci Polym Ed. 2017 Nov;28(16):1797-1825
pubmed: 28707508
ACS Biomater Sci Eng. 2022 Aug 8;8(8):3199-3219
pubmed: 35816626
Perspect Medicin Chem. 2014 Aug 28;6:25-64
pubmed: 25232278
Chem Eng J. 2023 Jan 1;455(Pt 2):
pubmed: 36644784